Feedback

Bone Morphogenetic Protein 2 (BMP-2) Aggregates Can be Solubilized by Albumin-Investigation of BMP-2 Aggregation by Light Scattering and Electrophoresis

ORCID
0000-0001-8731-0770
Affiliation/Institute
Institut für Pharmazeutische Technologie und Biopharmazie
Sundermann, Julius;
Affiliation/Institute
Institut für Medizinische und Pharmazeutische Chemie
Zagst, Holger; Kuntsche, Judith;
GND
121081796
Affiliation/Institute
Institut für Medizinische und Pharmazeutische Chemie
Wätzig, Hermann;
GND
120787512
Affiliation/Institute
Institut für Pharmazeutische Technologie und Biopharmazie
Bunjes, Heike

Bone morphogenetic protein 2 (BMP-2) has a high tendency to aggregate at physiological pH and physiological ionic strength, which can complicate the development of growth factor delivery systems. The aggregation behavior in differently concentrated BMP-2 solutions was investigated using dynamic and static light scattering. It was found that at higher concentrations larger aggregates are formed, whose size decreases again with increasing dilution. A solubilizing effect and therefore less aggregation was observed upon the addition of albumin. Imaged capillary isoelectric focusing and the simulation of the surface charges of BMP-2 were used to find a possible explanation for the unusually low solubility of BMP-2 at physiological pH. In addition to hydrophobic interactions, attractive electrostatic interactions might be decisive in the aggregation of BMP-2 due to the particular distribution of surface charges. These results help to better understand the solubility behavior of BMP-2 and thus support future pharmaceutical research and the development of new strategies for the augmentation of bone healing.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

Use and reproduction: